Skip to main content

Table 2 Analysis of the CMR parameters of the two groups

From: Novel insights into myocardial fibrosis in patients with new onset ST-elevation myocardial infarction following percutaneous coronary intervention through enhanced cardiac magnetic resonance imaging: a prospective cohort study

Variable

LGE < 16%

(n = 37)

LGE ≥ 16%

(n = 41)

p value

LVEDV (mL)

68.80 ± 17.96

77.34 ± 18.18

0.041

LVESV (mL)

29.93(23.34,39.25)

40.71(35.04,52.28)

0.001

LVEF (%)

53.00(49.50,59.50)

46.00(36.00,53.00)

0.002

Myocardial mass

93.05 ± 21.04

106.49 ± 26.35

0.016

MVO

11(29.73)

32(78.05)

0.000

WMA

17(45.95)

31(75.61)

0.007

GRS

27.71(24.02,35.32)

24.90(20.91,28.35)

0.013

GCS

16.28 ± 3.14

14.06 ± 2.84

0.002

GLS

13.02(10.89,14.22)

9.75(7.76,12.94)

0.004

IRS

17.70(13.36,26.36)

14.18(11.34,19.59)

0.005

ICS

11.70(10.90,15.88)

10.06(8.77,11.61)

0.001

ILS

11.96 ± 3.08

10.28 ± 3.67

0.033

  1. Note: CMR: cardiac magnetic resonance imaging; LGE: late gadolinium enhancement; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; LVEF: left ventricular ejection fraction; MVO: microvascular obstruction; WMA: wall motion abnormality; GRS: global radial strain; GCS: global circumferential strain; GLS: global longitudinal strain; IRS: infarcted segment radial strain; ICS: infarcted segment circumferential strain; ILS: infarcted segment longitudinal strain